Table 2.
Percentage of Enrollees Receiving Appropriate Care by Gender with Prevalence Ratios
| Quality Indicator | Women, % | Men, % | Unadjusted Relative Risk | P Value | Adjusted Relative Risk (95% CI) | P Value |
|---|---|---|---|---|---|---|
| Pneumococcal vaccination | 74.0 | 79.7 | 0.93 | <.01 | 0.98 (0.97–0.99) | <.01 |
| Influenza vaccination | 73.4 | 76.5 | 0.96 | <.01 | 0.99 (0.97–1.00) | .03 |
| Colorectal cancer screening | 68.9 | 69.9 | 0.99 | .03 | 0.99 (0.97–1.00) | .10 |
| Diabetic eye exam screen | 67.0 | 68.6 | 0.98 | .01 | 0.98 (0.96–1.00) | .10 |
| Annual HbA1c | 94.7 | 94.3 | 1.01 | .30 | 1.00 (0.99–1.01) | .71 |
| HbA1c <8.0 % | 61.1 | 62.0 | 0.99 | .20 | 1.05 (1.03–1.07) | <.01 |
| Aspirin after MI | 97.8 | 97.3 | 1.01 | .74 | 1.00 (0.96–1.02) | .72 |
| β-blocker after MI | 95.7 | 95.0 | 1.01 | .78 | 1.01 (0.95–1.03) | .75 |
| Blood pressure ≤140/90 mmHg | 48.0 | 47.4 | 1.01 | .47 | 0.96 (0.93–0.99) | .02 |
MI, myocardial infarction; HbA1c, hemoglobin A1c; CI, confidence interval.
Adjusted for age, region of country, hospital size, hospital location (urban vs nonurban), academic status of hospital or clinic.